Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PEGRProject Energy Reimagined Acquisition | $1.35 | $0.00 | 0.00% | $170.02M | 42.02K | 36.84K | - | Neutralremove | - | -84.98% | |||||
RAREUltragenyx Pharmaceutical | $35.49 | -$0.01 | arrow_drop_down0.02% | $3.29B | 222.11K | 35.45 | - | Neutralremove | - | -13.59% | |||||
RGLSRegulus Therapeutics | $7.89 | -$0.01 | arrow_drop_down0.18% | $543.48M | 1.66M | 7.90 | - | Neutralremove | - | 311.19% | |||||
CYHCommunity Health Systems | $3.69 | -$0.00 | arrow_drop_down0.13% | $601.91M | 1.20M | 3.73 | - | Neutralremove | - | 0.68% | |||||
IVVDInvivyd | $0.72 | -$0.03 | arrow_drop_down4.35% | $84.45M | 5.16M | 0.79 | - | Neutralremove | - | -66.29% | |||||
SLSSELLAS Life Sciences Group | $1.89 | $0.14 | arrow_drop_up7.95% | $159.64M | 2.61M | 1.86 | - | Neutralremove | - | 32.51% | |||||
BTGB2Gold | $3.35 | $0.05 | arrow_drop_up1.63% | $3.88B | 39.73M | 3.33 | - | Neutralremove | 3.01% | 18.97% | |||||
BMEABiomea Fusion | $1.45 | $0.01 | arrow_drop_up1.03% | $53.72M | 368.82K | 1.40 | - | Neutralremove | - | -87.34% | |||||
BITEBite Acquisition | $0.56 | $0.00 | 0.00% | $3.38M | 6.13K | 28.18K | - | Neutralremove | - | -93.37% | |||||
AVPTAvePoint | $18.29 | $0.16 | arrow_drop_up0.91% | $3.98B | 473.44K | 18.16 | - | Neutralremove | - | 95.66% | |||||
WELIntegrated Wellness Acquisition | $11.91 | -$0.04 | arrow_drop_down0.33% | $84.56M | 1.20K | 12.01 | - | Neutralremove | - | 3.65% | |||||
PIIIP3 Health Partners | $7.30 | -$0.30 | arrow_drop_down4.00% | $27.12M | 6.31K | 7.34 | - | Neutralremove | - | -70.89% | |||||
HYLNHyliion Holdings | $1.22 | $0.08 | arrow_drop_up7.45% | $254.08M | 2.24M | 1.17 | - | Neutralremove | - | -19.93% | |||||
CNSPCNS Pharmaceuticals | $1.08 | -$0.06 | arrow_drop_down5.24% | $4.11M | 151.26K | 1.11 | - | Neutralremove | - | -99.79% | |||||
RWAY RWAYZRunway Growth Finance Corp. - 8.00% Notes due 2027 | $25.11 | -$0.03 | arrow_drop_down0.11% | $7.32B | 106.00 | 25.11 | - | Neutralremove | - | -0.19% | |||||
ALZNAlzamend Neuro | $3.58 | $0.02 | arrow_drop_up0.56% | $2.41M | 32.58K | 3.58 | - | Neutralremove | - | -93.58% | |||||
FTFTFuture FinTech Group | $1.54 | -$0.07 | arrow_drop_down4.45% | $4.39M | 61.45K | 1.55 | - | Neutralremove | - | -81.44% | |||||
REALRealReal | $5.23 | $0.01 | arrow_drop_up0.28% | $596.01M | 1.48M | 5.22 | - | Neutralremove | - | 28.62% | |||||
BAOS BAOSBaosheng Media Group Holdings Limited Ordinary shares | $2.34 | $0.02 | arrow_drop_up0.84% | $3.68M | 29.22K | 2.41 | - | Neutralremove | - | -31.02% | |||||
BEATWHeartBeam | $0.53 | $0.53 | 0.00% | $15.13M | 1.81K | 0.53 | - | Neutralremove | - | 5.68% |
Showing 4941-4960 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools